XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.72

-1.2%

1:20 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (17303)	4/27/2007 1:55:48 AM
From: bob zagorin	of 17367

thanks. couple thoughts on isis... don't think its all in the price. there are very active shorts who have been spreadin g FUD about liver problems. look at the results for yourself but my layman's take is that these are just normal by-products of the drug's effectiveness... i think as the results are digested by the scientists and analyst community the stock price will move up... the next catalyst should be some additional news about partnership for further development of this drug.. as always, the past history of antisense (isis, gnta, avii) hangs over the stock and it is reasonable doubt. i think the second gen drugs are significantly better.. also isis has significant underlying value both for its patent and research estate (as in ALNY deal) and for its soon to be spun off Ibis division with its TIGER biosensor... jmho....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next